SEATTLE--()--Chris Rivera, President of the Washington Biotechnology & Biomedical Association (WBBA) announced today that Jay Inslee and Rob McKenna have been confirmed as speakers at the Governor’s Life Sciences Summit and Annual Meeting at the Meydenbauer Center in Bellevue, WA on Friday, October 26 - just days before the gubernatorial election. In his announcement, Mr. Rivera noted that with Governor Chris Gregoire and the gubernatorial candidates at the podium, attendance is expected to approach 1,000 executives from the life science industry throughout the Pacific Northwest, and demonstrates the importance of one of Washington’s largest and fastest growing job sectors.
“We are very excited to have Governor Chris Gregoire join us again as our keynote speaker. This will be the Governor’s 8th consecutive year keynoting the event, and her last as her second term comes to an end this year.”
In making the announcement, Mr. Rivera said, “We are very excited to have Governor Chris Gregoire join us again as our keynote speaker. This will be the Governor’s 8th consecutive year keynoting the event, and her last as her second term comes to an end this year.”
Governor Gregoire stated, “I am looking forward to speaking once again at the WBBA’s Governor’s Life Science Summit & Annual Meeting. Washington state’s life sciences community has some of the best researchers and organizations developing some of the greatest advancements in the field. While our state has seen tremendous growth in this industry, we know there’s incredible possibility for further growth. By expanding our life sciences industry — we are not only creating good jobs for Washingtonians, we are ultimately creating a healthier state and world.”
The slate of speakers will also include life science industry leaders Clay Siegall, CEO, Seattle Genetics, Inc.; Brian Webster, CEO, Physio-Control, Inc.; and H. Stewart Parker, CEO, Infectious Disease Research Institute (IDRI).
Following the keynote speakers, Mr. Rivera will release the 4th Annual Life Sciences Economic Impact Report for the state of Washington. Past economic reports have contained critical information regarding the number of direct and indirect life sciences jobs in the state, growth numbers within the industry over the past year, and other important statistical information for one of the state’s largest industry sectors.
The program will conclude with the announcement of two major association awards: the WBBA Innovation Award for major success within the life science industry, and the WBBA Volunteer of the Year Award recognizing a member for his/her tireless work within the association over the years.
About the WBBA
The Washington Biotechnology & Biomedical Association (WBBA) has over 480 member organizations and is an independent, non-profit 501(c)(6) trade association serving the life sciences industry in the state of Washington. It is completely resourced and supported by its members, including organizations engaged in, or supportive of, research, development and commercialization of life science innovation.
The WBBA’s Mission; “Supporting Innovation to Realization. From breakthrough discoveries to better health solutions”, drives its core strategic focus on;
- Innovation – working closely with and supporting our research institutions, inventors and entrepreneurs to broaden the impact of breakthrough discoveries.
- Capital – facilitating access to capital, especially early stage funding and strategic collaboration.
- Talent – helping to recruit, train and retain the talent needed to grow life sciences in Washington.
- Environment – ensuring that Washington is a great place to start, grow and retain the organizations needed to remain competitive and prosperous.